Ácido Fólico: nutriente redescubierto

Autores/as

  • María del Pilar Súarez de Ronderos Universidad de Costa Rica

DOI:

https://doi.org/10.51481/amc.v45i1.83

Palabras clave:

Folatos, ácido fólico, homicisteina, enfermedad cardiovascular , enfermedad tumoral

Resumen

Las funciones que en el organismo humano ejercen los folatos, referentes a la formación de eritrocitos y leucocitos en la médula ósea y a la prevención de daños en el desarrollo del tubo neural del niño durante la gestación, han sido bien estudiadas. En los últimos años, se han venido identificando funciones relacionadas con la salud cardiovascular y el desarrollo de enfermedad tumoral de los individuos. A este respecto, en esta revisión la autora pretende resaltar las funciones que ejercen los folatos en la salud humana, relacionadas con los niveles de homocisteína en suero y con la síntesis y reparación del ADN, lo cual ha sido relacionado respectivamente con el desarrollo de enfermedades cardiovasculares y algunos tipos de cáncer en humanos.

Descargas

Los datos de descargas todavía no están disponibles.

Citas

Mahan and Arlin. Nutrición y dietoterapia de Krause. Editorial Intera-mericana McGraw- Hill. Décima edición.2000.

Casanueva,kaufer-Horwitz,Perea-Lizano,Arroyo. Editorial Panameri-cana. Segunda edición.2001.

Whitney and Sizer. Nutrition:Concepts and controversies. Séptimaedición. Canadá.1997.

Brouwer,I; Dusseldorp,M; Thomas,C; Durán ,M; Hautvast,J; Eskes,T; Steegers-Theunissen,R. Low-dose folic acid supplementation de-creases plasma homocysteine concentrations:a randomized trial. En:American Journal of Clinical Nutrition. (1999). 66:99-104.

Majumdar,A. (2000). Chemo preventive role of folic acid in colon can-cer. Medical center and department of medicine,biochemistry and mo-lecular biology,and center for molecular medicine and genetics,Way-ne State University School of Medicine,Detroit,Michigan,U.S.A.

Bloom,H. Determinants of plasma homocysteine. En:American Jour-nal of Clinical Nutrition. (1998). 67:188.

Boushey,C Quantitative assessment of plasma homocysteina as a riskfactor for vascular disease. En:JAMA. (1995). 274:1049-1057.

Clarke,R; Daly,L; Robinson,K; Naughthen,E; Cahalane,S; Fowler,B; Grahan,I. Hiperhomocysteinemia:as independent risk factor forvascular disease. En:New England Journal of Medicine. (1991).324:1149-1155.

Brönstrup,A; Hages,M; Prinz-Langenohl,R; Pietrzik,K. (1998). Ef-fects of folic acid and vitamin B12 on plasma homocysteine concentra-tions in healthy, young women. En:American Journal of Clinical Nu-trition. 68:1104-1110.

Guttormsen,A; Schneede,J; Ueland,P; Retsum,H. (1996). Kinetics oftotal plasma homocysteine in subjects with hiperhomocysteinemia dueto folate or cobalamin deficiency. En:American Journal of Clinical Nu-trition.63:194-202.

Brattström,L; Cuskelly,G; Den Herjer,M; Naurath,H; Pietrzick,K;Saltzman,E; Ubbink,J. (1998). Lowering blood homocysteine with fo-lic acid based supplements:Meta analysis of randomized trials. En:Bri-tish Medical Journal. 316:894-898.

Nygard,O; Refsum,H; Ueland,P; Volsett,S. (1998). Major lifestyledeterminants of plasma total homocysteine distribution:The HordalandHomocysteine Study. En:American Journal of clinical nutrition. 67:263-270.

Selhub,J; Rosenberg,I. (1999). Serum total homocysteine concentra-tions in the third national Health and Nutrition Examinatiion survey(1991-1994):population reference ranges and contribution of vitaminsstatus to hingh serum concentrations. En:Ann Intern Med. 131:331-339.

Homocysteine Lowering Trialists ́ Collaboration. (1998). Loweringblood homocysteine with folic acid based supplements:meta analysisof randomised trials. En:British Medical Journal. 316:894-898.

Beresford,S; Boushey; C. Preventive Nutrition:the comprehensive gui-de for health professionals. Editorial Human Press Inc.1997.

Rimm,E; Walter,C,Willet,M; Frank,B; Sampson,L; Grahan,A; Man-son,J; Hennekens,Ch; Stampfer, J. (1998). Folate and vitamin B12from diet and supplements in relation to risk of coronary hearth disea-se among women. En. JAMA. 279(5):359-364.

Ridker,P; Manson,J; Buring,J; Shih,J; Matias,H; Hennekens,Ch.(1999). Homocysteine and risk of cardiovascular disease among post-menopausal women.en:JAMA. 281(19):1817-1821.

Mohan and Stansby. (1999). Nutritional hiperhomocysteinemia,evi-dence mounts for its role in vascular disease. En:British Medical Jour-nal. 318:1569-1570.

Wald, D,Bishop,L; Wald, N. (2001). Randomized trial of folic acidsuplementation and serum homocisteyne levels. En:Ann Intern Med.161:695-700.

Morrison,H; Schaubel,D; Desmeules,M; Wigle, D. (1996). Serumfolate and risk of fatal coronary heart disease. En:JAMA. 275:1893-1896.

Robinson,K; Arheart,K; Refsum,H. (1998). Low circulating folateand vitamin B6 concentrations:risk factors for stroke,peripheral vas-cular disease,and coronary artery disease. En:Circulation. 97:437-443.

Rimm,E; Willet,W; Hu,F. (1998). Folate and vitamin B6 from dietand suplements in relation to risk of coronary heart disease among wo-men. En:JAMA. 279:359-364.

Kangn,S; Wong,P; Malinow,M. (1992). Hiperhomocysteinemia as arisk factor for occlusive vascular disease. En:Ann Rev Nutr. 12:279-298.

Stamler,S; Slivka,A. (1996). Biological chemistre of thiols in the vas-culature and vascular-related disease. En:Nutrition Reviews. 54:34-37.

Ubbick,J. (1996). Will an increases dietary folate intake reduce the in-cidence of cardiovascular disease. En:Nutrition Reviews. 54:213.

Wattenberg,L. (1992). Inhibition of carcinogenesis by minor dietaryconstituents. En:Cancer Research. 52:2085S-2091S.

American Academy of Pediatrics. (1999). Folic acid for the preventionof neural tube defects. En:Pediatrics. 104(2):325-327.

Hall,J. (2000). Folic acid:the opportunity that still exists. En:CanadianMedical Association Journal. 162:1571-1572.

Fairfield,K; Fletcher,R. (2002). Vitamins for chronic disease preven-tion in adults. En:JAMA. 287 (23):3116 –3126.

Garland,C; Barret-Connor,E; Rossef,A. (1985). Dietary vitamin andcalcium and risk of colorectal cancer:a 19 year prospective study inmen. En:Lancet. 1:307-309.

Molloy,A. M.; Scott,J. M. (2001). Folates and prevention of disease.En:Public Health Nutr. 4 (2B):601-9

Prinz-Langenohl,R.; Fohr,I.; Pietrzik,K. (2001). Beneficial role forfolate in the prevention of colorectal and breast cancer. En:EuropeanJournal of Nutrition. 40 (3):98-105

Szarka,C,Grana,G. (1994). Chemoprevention of cancer. En:Curr.Prob. Cancer. 18:8-79.

Nensy, Y;Arlow,F; Majumbar,A. (1995). Aging:increased responsive-ness of colorectal mucosa to carcinogen stimulation and protective ro-le of folic acid. En:Dig. Dis. Sci. 40:396-401. 35.Meenan,J; O’Hallinan,E; Scott,J; Weie, D. (1997). Epithelea cell fo-late depletion occurs in neoplastic but not adjacent normal colon muco-sa. En:Gastroenterology. 112:1163-1168

Kim,Y; Solomon,R; Choi,S. (1994). Dietary folate protects against thedevelopment of macroscopic colonic neoplasms in a dose dependentmanner in the dimethilhidrazine rat model. En:Gastroenterology. 106:A402.

Lashner, B. (1993). Red blood cell is associated with development ofdysplasia and cancer in ulcerative colitis. En:Cancer Res. Clin. Oncol.91:549-554.

Zhang,S; Hunter,D; Hankinson,S; Giovannucci,E; Rosner,B; Col-ditz,G; Speizer,F; Willet,W. (1999). A prospective study of folate in-take and the risk of breast cancer. En:JAMA. 281:1632-1637.

Fuchs,C; Willet,W ; Colditz,G; Hunter,D; Stampher,M; Speizer,F;Giovannucci,E. (2002). The influence of folate and multivitamin useon the familial risk of colon cancer in women. En:Cancer Epidemiolbiomarkers prev. 11(3):227-234.

Lashner,B; Heidenreich,P; Su,G. (1989). Effect of folic supplementa-tion on incidence of dysplasia and cancer in chronic ulcerative colitis:a case controlled study. En:Gastroenterology. 97:255-259.

Su,L; Arab,L. (2001). Nutritional status of folate and colon cancerrisk:evidence from NHANES I epidemiologic follow-up study. En:Ann Epidemiol. 11:65-72.

Cravo,M; Mason,J; Yoheshwar, D. (1995). Folate status and adenoma-tous colonic polyps:a colonoscopically controlled study. En:Dis,Co-lon Rectum. 38:64-68.

James,S; Basnakian,A; Miller, B. (1994). In vitro folate deficiency in-duces deoxynucleotide pool imbalance, apoptosis,and mutagenesis inchinese hamster ovary cells. En:Cancer res. 94:5075-5080.

Zhang,S; Hunter,D; Hankinson,S. (1999). A prospective study of fo-late intake and risk of breast cancer. En:JAMA. 281:1632-1637.

Boppana,S; Sarkar,F; Liu,L; Li,Y; Khan,A; Kucuk,K; Mahacala,K;Jaszewiski,R. Folic acid:Regulation or growth of colon and gastriccancer cell lines. En:Gastroenterology. 114:A567.

Buttherworth,C. (1992). Effects of folate on cervical cancer,synergismamong risk factors. En:Ann NY Acad Sci. 669:293-299.

Muir,C. (1992). Folate deficiency and cervical dysplasia. En:Journalof the American Medical Association. 267:528-533.

Giovannucci,E; Stampher,M; Colditz,G; Hunter,D; Fuchs,C; Rosner,B; Speizer,F; Willet,W. (1998). Multivitamin use, folate and coloncancer in women in the Nurses Heath study. En:Ann Intern Med. 129:517-524.

Descargas

Publicado

2003-01-01

Cómo citar

Súarez de Ronderos, M. del P. (2003). Ácido Fólico: nutriente redescubierto. Acta Médica Costarricense, 45(1), 5–9. https://doi.org/10.51481/amc.v45i1.83